Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor.

Burns HD, Van Laere K, Sanabria-Bohórquez S, Hamill TG, Bormans G, Eng WS, Gibson R, Ryan C, Connolly B, Patel S, Krause S, Vanko A, Van Hecken A, Dupont P, De Lepeleire I, Rothenberg P, Stoch SA, Cote J, Hagmann WK, Jewell JP, Lin LS, Liu P, Goulet MT, Gottesdiener K, Wagner JA, de Hoon J, Mortelmans L, Fong TM, Hargreaves RJ.

Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5. Epub 2007 May 29.

2.

Imaging of the brain cannabinoid system.

Lindsey KP, Glaser ST, Gatley SJ.

Handb Exp Pharmacol. 2005;(168):425-43. Review.

PMID:
16596783
3.
4.

Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.

Horti AG, Van Laere K.

Curr Pharm Des. 2008;14(31):3363-83. Review.

PMID:
19075713
5.

Positron emission tomography in CNS drug discovery and drug monitoring.

Piel M, Vernaleken I, Rösch F.

J Med Chem. 2014 Nov 26;57(22):9232-58. doi: 10.1021/jm5001858. Epub 2014 Sep 10. Review.

PMID:
25144329
6.

N-[2-(3-cyanophenyl)-3-(4-(2-[18F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2008 Feb 28 [updated 2008 Mar 25].

7.

Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.

Ahamed M, Verbruggen A, Bormans G.

J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):207-14. doi: 10.1002/jlcr.3017. Review.

PMID:
24285327
8.

N-(4-[18F]Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 18 [updated 2010 Oct 28].

9.

(3R,5R)-5-(3-[18F]Fluoromethoxy-d2)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 6 [updated 2010 Oct 7].

10.

(3R,5R)-5-(3-(2-[18F]Fluoroethoxy)phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 6 [updated 2010 Oct 7].

11.

(3R,5R)-5-(3-[18F]Fluoromethoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 6 [updated 2010 Oct 7].

12.

[Carbonyl-11C]-N-(4-Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 18 [updated 2010 Oct 28].

13.

(3R,5R)-5-(3-[11C]Methoxy-phenyl)-3-((R)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one.

Leung K, Donohue S.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Aug 6 [updated 2010 Oct 7].

14.

Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders.

Virdee K, Cumming P, Caprioli D, Jupp B, Rominger A, Aigbirhio FI, Fryer TD, Riss PJ, Dalley JW.

Neurosci Biobehav Rev. 2012 Apr;36(4):1188-216. doi: 10.1016/j.neubiorev.2012.01.009. Epub 2012 Feb 8. Review.

PMID:
22342372
15.

Microfluidics: a groundbreaking technology for PET tracer production?

Rensch C, Jackson A, Lindner S, Salvamoser R, Samper V, Riese S, Bartenstein P, Wängler C, Wängler B.

Molecules. 2013 Jul 5;18(7):7930-56. doi: 10.3390/molecules18077930. Review.

16.

Translational PET imaging research.

Hargreaves RJ, Rabiner EA.

Neurobiol Dis. 2014 Jan;61:32-8. doi: 10.1016/j.nbd.2013.08.017. Epub 2013 Sep 17. Review.

PMID:
24055214
17.

A philosophy for CNS radiotracer design.

Van de Bittner GC, Ricq EL, Hooker JM.

Acc Chem Res. 2014 Oct 21;47(10):3127-34. doi: 10.1021/ar500233s. Epub 2014 Oct 1. Review.

18.

PET and SPECT tracers for glutamate receptors.

Majo VJ, Prabhakaran J, Mann JJ, Kumar JS.

Drug Discov Today. 2013 Feb;18(3-4):173-84. doi: 10.1016/j.drudis.2012.10.004. Epub 2012 Oct 22. Review.

PMID:
23092894
19.
20.

PET Neurochemical Imaging Modes.

Placzek MS, Zhao W, Wey HY, Morin TM, Hooker JM.

Semin Nucl Med. 2016 Jan;46(1):20-7. doi: 10.1053/j.semnuclmed.2015.09.001. Review.

PMID:
26687854

Supplemental Content

Support Center